Header cover image

Chinese (SSE) Healthcare Distributors Industry Analysis

UpdatedJun 14, 2025
DataAggregated Company Financials
Companies23
  • 7D1.1%
  • 3M2.0%
  • 1Y7.5%
  • YTDn/a

In the last week, the Healthcare Distributors industry is up 1.8%, with Qingdao Baheal Medical leading the way, up 29%. During this same period, the HPGC Renmintongtai Pharmaceutical underperformed, falling 17%. This means that the industry has gained 8.7% over the past year. As for the next few years, earnings are expected to grow by 12% per annum.

Industry Valuation and Performance

Has the Chinese Healthcare Distributors Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 14 Jun 2025CN¥316.0bCN¥905.9bCN¥16.8b23.6x18.8x0.3x
Mon, 12 May 2025CN¥297.9bCN¥908.5bCN¥16.8b23.4x17.8x0.3x
Wed, 09 Apr 2025CN¥288.1bCN¥902.7bCN¥15.6b16.4x18.5x0.3x
Fri, 07 Mar 2025CN¥300.5bCN¥910.6bCN¥16.5b17.6x18.3x0.3x
Sun, 02 Feb 2025CN¥300.9bCN¥910.6bCN¥16.5b17.5x18.3x0.3x
Tue, 31 Dec 2024CN¥318.8bCN¥910.6bCN¥16.5b18.8x19.4x0.4x
Thu, 28 Nov 2024CN¥328.7bCN¥910.6bCN¥16.5b19.6x20x0.4x
Sat, 26 Oct 2024CN¥319.4bCN¥904.3bCN¥16.5b18.8x19.3x0.4x
Mon, 23 Sep 2024CN¥262.1bCN¥900.2bCN¥16.4b16.2x16x0.3x
Wed, 21 Aug 2024CN¥282.3bCN¥904.3bCN¥16.6b15.3x17x0.3x
Fri, 19 Jul 2024CN¥279.7bCN¥904.3bCN¥16.5b15x17x0.3x
Sun, 16 Jun 2024CN¥293.5bCN¥904.3bCN¥16.5b16.3x17.8x0.3x
Tue, 14 May 2024CN¥323.4bCN¥904.3bCN¥16.5b17.1x19.6x0.4x
Thu, 11 Apr 2024CN¥296.4bCN¥903.3bCN¥14.8b15.2x20x0.3x
Sat, 09 Mar 2024CN¥306.3bCN¥894.8bCN¥15.5b14.5x19.8x0.3x
Mon, 05 Feb 2024CN¥275.4bCN¥893.5bCN¥15.5b12.8x17.8x0.3x
Wed, 03 Jan 2024CN¥325.9bCN¥893.5bCN¥15.5b15.3x21.1x0.4x
Fri, 01 Dec 2023CN¥339.9bCN¥893.5bCN¥15.5b15.8x22x0.4x
Sun, 29 Oct 2023CN¥327.3bCN¥899.6bCN¥15.8b14.8x20.7x0.4x
Tue, 26 Sep 2023CN¥333.8bCN¥897.9bCN¥15.9b16.2x20.9x0.4x
Thu, 24 Aug 2023CN¥322.1bCN¥871.6bCN¥17.3b14.4x18.6x0.4x
Sat, 22 Jul 2023CN¥353.2bCN¥869.7bCN¥17.2b14.3x20.5x0.4x
Mon, 19 Jun 2023CN¥354.1bCN¥863.1bCN¥17.1b14.4x20.7x0.4x
Wed, 17 May 2023CN¥363.9bCN¥863.0bCN¥17.1b15.8x21.3x0.4x
Fri, 14 Apr 2023CN¥370.9bCN¥825.1bCN¥18.8b16.4x19.7x0.4x
Sun, 12 Mar 2023CN¥349.8bCN¥822.0bCN¥18.4b15.2x19x0.4x
Tue, 07 Feb 2023CN¥338.4bCN¥821.4bCN¥18.2b14.9x18.6x0.4x
Thu, 05 Jan 2023CN¥331.8bCN¥821.1bCN¥18.2b16.2x18.2x0.4x
Sat, 03 Dec 2022CN¥338.7bCN¥821.1bCN¥18.2b18.2x18.6x0.4x
Mon, 31 Oct 2022CN¥289.8bCN¥786.3bCN¥17.6b14.7x16.4x0.4x
Wed, 28 Sep 2022CN¥273.1bCN¥764.7bCN¥16.8b14.9x16.3x0.4x
Fri, 26 Aug 2022CN¥286.4bCN¥765.3bCN¥15.6b20.9x18.3x0.4x
Sun, 24 Jul 2022CN¥312.5bCN¥766.9bCN¥17.6b15.2x17.8x0.4x
Tue, 21 Jun 2022CN¥315.1bCN¥766.9bCN¥17.6b16x17.9x0.4x
Price to Earnings Ratio

17.9x


Total Market Cap: CN¥315.1bTotal Earnings: CN¥17.6bTotal Revenue: CN¥766.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Healthcare Distributors Industry Price to Earnings3Y Average 19x202320242025
Current Industry PE
  • Investors are relatively neutral on the Chinese Healthcare Distributors industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 19.0x.
  • The industry is trading close to its 3-year average PS ratio of 0.37x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Distributors industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Chinese Healthcare Distributors compare with similar industries?

CN Market-0.46%
Healthcare1.02%
Healthcare Services-0.0083%
Healthcare Distributors1.10%
Healthcare Services-0.26%
Healthcare Facilities-1.80%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
301015 Qingdao Baheal MedicalCN¥24.3628.9%
+CN¥2.9b
-15.3%PE21.7x
000963 Huadong MedicineCN¥44.553.4%
+CN¥2.6b
43.9%PE21.9x
600998 Jointown Pharmaceutical GroupCN¥5.441.7%
+CN¥448.8m
3.4%PE9.2x
000028 China National Accord MedicinesCN¥25.480.4%
+CN¥55.7m
-26.4%PE24.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

301015

CN¥24.36

Qingdao Baheal Medical

7D

28.9%

1Y

-15.3%

000028

CN¥25.48

China National Accord Medicines

7D

0.4%

1Y

-26.4%

600829

CN¥7.35

HPGC Renmintongtai Pharmaceutical

7D

-16.7%

1Y

25.4%

000503

CN¥10.06

China Reform Health Management and Services Group

7D

-2.4%

1Y

39.3%

000963

CN¥44.55

Huadong Medicine

7D

3.4%

1Y

43.9%

601607

CN¥18.35

Shanghai Pharmaceuticals Holding

7D

-0.5%

1Y

-0.7%

301060

CN¥9.33

Shanghai Labway Clinical Laboratory

7D

-2.9%

1Y

3.9%

000950

CN¥5.04

C.Q. Pharmaceutical Holding

7D

-1.4%

1Y

-4.2%

000078

CN¥2.51

Shenzhen Neptunus Bioengineering

7D

-2.0%

1Y

17.3%

600056

CN¥10.43

China Meheco Group

7D

-0.8%

1Y

-2.4%

600511

CN¥30.34

China National Medicines

7D

-0.6%

1Y

-7.2%